Study Watch vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Study Watch

by Verily Life Sciences

iCAC Device

by Bunkerhill Health

AI Verdict

Study Watch is a wearable device designed for continuous physiological monitoring in clinical research, collecting real-time data such as ECG and heart rate. Conversely, the iCAC Device is an AI algorithm that analyzes existing chest CT scans to identify and quantify coronary artery calcium. While both tools contribute to cardiovascular health insights, they do so through entirely different data modalities and use cases, making them adjacent rather than direct competitors.

Choose Study Watch if…

Choose the Verily Study Watch if your clinical research requires continuous, high-fidelity physiological data collection from participants over extended periods. This device is ideal for studies focused on developing and validating AI-enabled precision health solutions that rely on multi-modal sensor data like ECG, heart rate, and movement for in-depth analysis.

View Study Watch →

Choose iCAC Device if…

Choose Bunkerhill Health's iCAC Device if you aim to opportunistically screen for cardiovascular disease risk by leveraging existing, routine non-contrast chest CT scans. This AI algorithm is best suited for healthcare systems looking to efficiently identify and quantify coronary artery calcium, providing valuable adjunctive information to radiologists for early detection and intervention.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Study Watch	iCAC Device
Pricing	Not publicly available (device for clinical research and partnerships)	Contact for pricing
Deployment	Cloud (data uploaded from device to Verily's cloud platform).	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status	Yes AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

iCAC Device

The iCAC Device integrates seamlessly into existing radiology workflows by analyzing routine CT scans, requiring minimal additional effort from clinicians. In contrast, the Study Watch, as a wearable, necessitates patient compliance for wearing and charging, and involves logistical management for device deployment and data collection in a research setting.

Clinical Value

iCAC Device

The iCAC Device offers direct, actionable clinical value by quantifying coronary artery calcium from existing CT scans, a validated marker for cardiovascular disease risk. This provides immediate diagnostic and prognostic information to clinicians. While Study Watch provides valuable continuous physiological data for research, its direct clinical actionability for individual patient management is less immediate compared to iCAC's specific diagnostic output.

Pricing & Value

iCAC Device

Both tools lack public pricing transparency, making a direct cost comparison impossible. However, the iCAC Device offers potentially higher value by leveraging existing, routinely acquired CT scans to provide critical cardiovascular risk information without requiring additional patient procedures or dedicated hardware. This opportunistic screening approach can maximize the utility of existing data, potentially leading to cost efficiencies in risk assessment.

Enterprise Readiness

iCAC Device

The iCAC Device demonstrates strong enterprise readiness through its FDA clearance and direct integration with standard healthcare IT systems like PACS, DICOM routers, and EHRs via the Carebricks platform. While Study Watch is also FDA-cleared and states HIPAA compliance, the ongoing lawsuit alleging BAA/HIPAA breaches against Verily introduces a significant risk factor for enterprise adoption.

Innovation

iCAC Device

The iCAC Device demonstrates greater innovation by leveraging deep-learning AI to opportunistically identify and quantify coronary artery calcium from existing, routine CT scans. This transforms readily available imaging data into a powerful cardiovascular risk assessment tool without requiring additional patient procedures. While Study Watch offers advanced continuous monitoring, the concept of opportunistic screening using AI on existing data represents a more disruptive and broadly impactful innovation in clinical practice.

Support & Docs

Tie

Neither the provided structured facts nor general web searches yielded specific public information regarding the level of support or documentation available for either the Verily Study Watch or the Bunkerhill Health iCAC Device. Therefore, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Study Watch	iCAC Device
Tool Name	Study Watch	iCAC Device
Primary Use Case	Non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement.	Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
Company	Verily Life Sciences	Bunkerhill Health
Data Input Type	Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements).	Routine, non-contrast, non-gated chest CT scans.
Key Analytical Output	Cloud-based data processing with algorithms and machine learning, on-demand single-channel ECG, irregular pulse monitor.	Estimates presence and quantity of coronary artery calcium (CAC), visual representation of estimated CAC segmentation, exact and four-category quantitative estimates of CAC burden in Agatston units.

Videos

Demos, reviews, and walkthroughs featuring Study Watch and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool specifically integrate into existing clinical workflows for patient care, considering Tool A's research focus and Tool B's opportunistic screening approach?

Verily Study Watch (Tool A) is primarily designed for continuous physiological monitoring in clinical research, with data uploaded to Verily's cloud platform. While it can support individual patient care by providing data to healthcare professionals via a web portal, its direct integration into routine clinical workflows for immediate diagnostic or treatment decisions is less explicit than Tool B. Bunkerhill Health's iCAC Device (Tool B) is a Software as a Medical Device (SaMD) that integrates with existing PACS or DICOM routers to analyze routine chest CT scans, aiming to opportunistically identify coronary artery calcium (CAC) and streamline risk stratification without disrupting current imaging workflows.

What is the depth of EHR integration for each tool, and what specific data points or insights are automatically pushed into the patient's record to aid clinical decision-making?

For Verily Study Watch (Tool A), data is collected and processed in Verily's cloud platform, and while it aims to bridge research and care by integrating with EHR data, the specific data elements automatically pushed into a patient's EHR for direct clinical decision-making are not detailed. Bunkerhill Health's iCAC Device (Tool B) integrates with EHRs via the Carebricks platform, pushing quantitative estimates of CAC burden in Agatston units and visual representations of estimated CAC segmentation to aid radiologists and cardiologists in patient risk assessment and follow-up.

What are the reported accuracy and sensitivity metrics for each tool's core function, and how do these translate into tangible clinical benefits or improved diagnostic confidence for physicians?

For Verily Study Watch (Tool A), studies have shown its ability to accurately classify sleep vs. wake with a sensitivity of 0.97 and specificity of 0.70, and its ECG feature has demonstrated qualitative clinical equivalence to industry-standard 12-lead ECG devices. For Bunkerhill Health's iCAC Device (Tool B), its performance was validated in a retrospective study, demonstrating an overall alignment rate of 79.7% between device output calcium score groups and ground truth groups, with primary acceptance criteria of 73% overall alignment and at least 65% positive predictive value for each of four calcium score groupings. These metrics for Tool B translate to improved diagnostic confidence by providing automated, quantitative CAC assessment from existing CT scans, aiding in early cardiovascular disease detection and risk stratification.

What is the expected learning curve for physicians and their teams to effectively utilize and interpret the output from each tool within their respective specialties?

For Verily Study Watch (Tool A), the learning curve for physicians involves interpreting continuous physiological data from a research context, though patient usage has been reported as easy to explain. For Bunkerhill Health's iCAC Device (Tool B), the learning curve primarily involves radiologists and cardiologists understanding the AI-generated CAC scores and segmentations, which are designed to integrate seamlessly into existing imaging workflows and provide adjunctive information.

Beyond HIPAA, what specific security measures are implemented to protect patient data within each tool's ecosystem, and what audit-trail features are available to track data access and algorithm decisions?

Verily Study Watch (Tool A) incorporates internal data storage and encryption on the device, and Verily's cloud platform utilizes strong encryption (in-transit and at-rest), tightly restricted role-based access, and undergoes independent cybersecurity audits like SOC 2 Type II and ISO/IEC 27001 certifications. Bunkerhill Health's iCAC Device (Tool B) integrates with PACS or DICOM routers and operates within the Carebricks platform, which includes security features such as data encryption, role-based access control (RBAC), and audit logs to track algorithm decisions and user interactions.